Rosuvastatin safety and side effects
Pro Research Analysisby 
Searched over 200M research papers
Rosuvastatin Safety Profile Compared to Other Statins
Rosuvastatin is a potent statin used to lower cholesterol and reduce cardiovascular risk. Large clinical trials and real-world studies show that rosuvastatin generally has a safety profile similar to other statins, with most patients tolerating the drug well and experiencing few serious side effects 1245+2 MORE. In a large observational study involving over 14,000 patients, the rate of adverse events was low (1.63%), and there were no significant cases of statin-associated myopathy, liver toxicity, or new-onset diabetes . In heart transplant patients, rosuvastatin provided better cholesterol control without increasing side effects compared to other statins .
Common and Serious Side Effects of Rosuvastatin
Muscle-Related Side Effects (Myopathy and Rhabdomyolysis)
Like all statins, rosuvastatin can cause muscle-related side effects, including myopathy (muscle pain or weakness) and, rarely, rhabdomyolysis (a serious muscle breakdown). The risk of these side effects is similar to other statins at standard doses (up to 40 mg daily) 256. At higher doses (80 mg, which is not commonly prescribed), the risk of myopathy and rhabdomyolysis increases . Animal studies suggest that rosuvastatin may cause milder muscle toxicity compared to atorvastatin .
Liver and Kidney Effects
Rosuvastatin can cause mild, temporary increases in liver enzymes, but this is no more common than with other statins and rarely leads to significant liver injury 15. Routine liver enzyme monitoring may not be necessary for most patients . Some patients may experience transient proteinuria (protein in the urine), but long-term use does not appear to harm kidney function and may even improve it slightly . However, some post-marketing analyses have reported higher rates of kidney-related adverse events (such as proteinuria, nephropathy, and renal failure) with rosuvastatin compared to other statins, especially early in treatment and at lower doses 310.
Other Side Effects
Gastrointestinal symptoms (such as nausea, diarrhea, and abdominal pain), headache, fatigue, and dizziness are among the most frequently reported side effects, especially when rosuvastatin is combined with other lipid-lowering drugs like fenofibrate . Women may be more susceptible to these side effects . In large studies, the overall rate of these side effects remains low .
Safety in Special Populations and Drug Interactions
Rosuvastatin is generally well tolerated in diverse patient groups, including those with heart transplants and those with multiple risk factors for cardiovascular disease 79. However, certain drug interactions (with cyclosporine, gemfibrozil, warfarin, and antacids) can increase the risk of side effects and should be monitored closely . Combination therapy with fenofibrate increases the risk of muscle and gastrointestinal side effects, so extra caution is advised .
Post-Marketing Surveillance and Ongoing Monitoring
Post-marketing surveillance has identified a slightly higher rate of serious adverse events (such as rhabdomyolysis and kidney problems) with rosuvastatin compared to some other statins, especially in the first year of use and at lower doses 310. However, the absolute number of these events is very small, and most patients use rosuvastatin safely without complications . Ongoing monitoring of kidney function and muscle symptoms is recommended, especially in patients with additional risk factors .
Conclusion
Rosuvastatin is a highly effective statin with a safety profile similar to other drugs in its class for most patients. The risk of serious side effects is low, but muscle and kidney-related adverse events can occur, particularly at higher doses or in combination with other medications. Regular monitoring and careful patient selection can help minimize risks and ensure safe, effective cholesterol management with rosuvastatin 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic
The Safety of Rosuvastatin as Used in Common Clinical Practice: A Postmarketing Analysis
Rosuvastatin is more likely to be associated with serious adverse events like rhabdomyolysis, proteinuria, nephropathy, or renal failure compared to other widely used statins.
Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programme
Rosuvastatin has a well-tolerated safety profile, with a comprehensive pharmacoepidemiology programme assessing over 50 000 patients to confirm its benefits and risks.
Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
Rosuvastatin effectively lowers LDL cholesterol and non-HDL-cholesterol levels, enabling more patients to reach their LDL cholesterol goals with an acceptable safety profile compared to other statins.
DOI